Cervical Cytology DNA Methylation for Cervical Cancer Screening

Not yet recruitingOBSERVATIONAL

Enrollment

30,000

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions

Cervical CancerDNA MethylationCytologyHuman Papillomavirus InfectionCervical Intraepithelial NeoplasiaCancer Screening

Interventions

DIAGNOSTIC_TEST

human PAX1 and JAM3 gene methylation assays (PAX1m/JAM3m)

PAX1m/JAM3m, with or without HPV testing and cytological pathology for cervical cancer screening

Trial Locations (1)

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Lei Li

OTHER

NCT06557954 - Cervical Cytology DNA Methylation for Cervical Cancer Screening | Biotech Hunter | Biotech Hunter